IL7 and idiopathic CD4 lymphocytopenia: Interestingly, high dose IL-7 responses were significantly lower in the ICL group (range: 64.4–95.6%; p = 0.01), with a subset of ICL patients showing clear impairment of STAT5 activation (example in Fig. 1B).